P3 Health Partners Inc.
PIII
$8.89
$0.222.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.87% | 25.58% | 15.22% | 28.61% | 34.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.87% | 25.58% | 15.22% | 28.61% | 34.33% |
| Cost of Revenue | 11.57% | 43.94% | 20.81% | 33.79% | 36.59% |
| Gross Profit | -89.92% | -535.83% | -47.84% | -61.04% | -89.86% |
| SG&A Expenses | 26.54% | -0.49% | -3.76% | -28.26% | -39.29% |
| Depreciation & Amortization | -2.22% | -0.22% | -0.40% | 0.00% | -1.67% |
| Other Operating Expenses | 1,234.18% | 245.47% | -68.84% | -80.54% | -148.62% |
| Total Operating Expenses | 21.89% | 47.53% | 17.24% | 23.21% | 24.11% |
| Operating Income | -103.00% | -234.68% | -48.98% | 10.21% | 12.03% |
| Income Before Tax | -84.43% | -188.68% | -1.64% | 8.87% | 87.31% |
| Income Tax Expenses | 180.25% | -975.00% | 328.32% | 614.48% | -5.10% |
| Earnings from Continuing Operations | -86.88% | -175.82% | -4.32% | 5.42% | 87.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 61.60% | 134.81% | -5.70% | -28.54% | -90.04% |
| Net Income | -130.21% | -249.82% | -22.45% | -103.28% | 72.92% |
| EBIT | -103.00% | -234.68% | -48.98% | 10.21% | 12.03% |
| EBITDA | -156.40% | -656.40% | -1,390.63% | 18.28% | 16.50% |
| EPS Basic | -127.68% | -146.76% | 3.72% | 28.90% | 90.23% |
| Normalized Basic EPS | -757.09% | -1,150.52% | -174.19% | -96.07% | -99.86% |
| EPS Diluted | 3.09% | -163.26% | -61.27% | 27.68% | 73.48% |
| Normalized Diluted EPS | -757.09% | -2,927.13% | -170.97% | -96.07% | -99.86% |
| Average Basic Shares Outstanding | 1.11% | 41.76% | 27.13% | 185.92% | 177.17% |
| Average Diluted Shares Outstanding | 1.11% | -47.33% | 31.30% | 185.92% | 177.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |